Skip to content
Main Menu
Donate!
Contact
Personal directory
Intranet
Suppliers
En
Menu Toggle
Ca
Es
Search
Search for:
Below Header
The Institute
Research
Services
Innovation
News & Events
Scientific culture
Home
Translational Medicine Area
Infectious disease and transplantation Program
Innate Immunity and Pathology of the Critical patient
Innate Immunity and Pathology of the Critical patient
18/11/2020
Bellvitge will study the application of artificial intelligence in the treatment of Covid-19 in ICUs
08/04/2020
The health department will finance 3 IDIBELL’s projects on COVID-19
23/03/2020
An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program
29/05/2019
SeptiLoop receives € 100,000 to develop a rapid diagnostic kit for sepsis
13/12/2018
IDIBELL and Bellvitge University Hospital develop a new treatment to fight against hospital infections
22/10/2018
IDIBELL’s health innovation model visits Barcelona and Japan
28/05/2018
Green light to REMAB, a new IDIBELL Spin-Off
18/12/2017
A new model to overcome rejection in xenotransplantation
11/01/2016
Genetic engineering to prevent rejection in xenotransplantation
25/11/2013
Researchers describe one mechanism that favors rejection in transplantation of porcine cartilage in humans
1
2
Next »
Scroll to Top
This site uses cookies
Find out more
Okay, thank you